Surgical site infections (SSIs) are the most common types of healthcare-associated infections (HAIs). These infections lead to longer hospital stays, and the patients may require additional surgical procedures and intensive care. The risks associated with SSIs often lead to morbidity and mortality, owing to which healthcare professionals across the world are using SSI products. Thus, the rising cases of SSIs will boost the adoption of such products in healthcare facilities. For instance, according to the European Center for Disease Prevention and Control (ECDC), around 543,149 SSI cases are reported annually in the European Union (EU) nations.
At present, hospitals, ambulatory surgery centers (ASCs), and clinics are using clippers, surgical drapes, patient-warming products, surgical staff clothing, wound care supplementary products, wound irrigation products, wound care dressings, antibiotic prophylaxis products, and antiseptics and disinfectants, to prevent SSIs. In the past, antibiotic prophylaxis products were adopted in the highest quantity to avoid infection and contamination during the course of treatment. Whereas, in the coming years, antiseptics and disinfectants will be consumed at the highest pace, due to the increasing incidence of SSIs, worldwide.
Browse report with detailed COVID-19 impact analysis on Surgical Site Infection Market Competitive Landscape Report
According to P&S Intelligence, North America adopted the highest quantity of SSI prevention products in 2017, owing to the presence of developed healthcare infrastructure, subsequent surge in number of surgical procedures, and strong presence of prominent SSI product manufacturers, in the region. Additionally, the booming elderly population and mounting public awareness about SSIs are also fueling the need for SSI products in North America. As per the World Bank, nearly 18% and 17% of the population of Canada and the U.S., respectively, were aged 65 years and above in 2020.
Whereas, the Asia-Pacific (APAC) surgical site infection market is expected to display the fastest growth throughout the forecast period. This will be due to the surging geriatric population, rising prevalence of SSIs, developing healthcare infrastructure, and increasing adoption of technologically advanced products. For instance, the United Nations Population Fund (UNFPA) forecasts that the population of people above 60 years of age in APAC will reach around 1.3 billion by 2050. Therefore, by 2050, one in four people in the region will be over 60 years old.